Floatz logo

Mitoxantrone

Children

Cancer Institute and Hospital, Chinese Academy of Medical SciencesSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

13 Active assets in the Children cohort.

Asset / SponsorPhaseRating
ERGOCALCIFEROLUM
Chulalongkorn University
Phase 4B
Damoctocog Alfa Pegol
Bayer
Phase 3B
bay94-9027
Bayer
Phase 3B
dn-101
Chulalongkorn University
Phase 4B
Nivolumab
St. Petersburg State Pavlov Medical University
Phase 2B

View all 16 →

Same molecule, other indications

Mitoxantrone is also rated in:

acute promyelocytic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
myeloid neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →